CTECConvatec Group PLC
206.60GBp+0.58%Mkt Cap: 4.09B GBpP/E: 34.87Last update: 2026-05-13

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company of…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)34.87
P/E (Forward)12.47
PEG1.42
P/B3.58
P/S1.67
EV/EBITDA9.40
EV/Revenue2.26
EPS (TTM)0.06
EPS (Forward)0.17
Cash Flow & Leverage
FCF Yield5.91%
FCF Margin9.90%
Operating CF470.00M GBp
CapEx (TTM)185.00M GBp
Net Debt/EBITDA2.47
Net Debt1.45B GBp
Technical
SMA 50222.69 (-7.2%)
SMA 200232.91 (-11.3%)
Beta0.78
S&P 52W Chg24.23%
Avg Vol (30d)11.41M
Avg Vol (10d)8.28M
Technical Indicators
RSI (14)37.6
MACD-6.3145
MACD Signal-5.0894
MACD Hist.-1.2252
BB Upper245.03 GBp
BB Middle219.24 GBp
BB Lower193.44 GBp
BB Width23.53%
ATR (14)6.330 GBp
Vol Ratio (20d)0.39x
52W Range
202.204% of range311.20
52W High311.20 GBp
52W Low202.20 GBp
Profitability
Gross Margin56.21%
EBITDA Margin24.07%
Profit Margin7.18%
Oper. Margin18.08%
ROE11.53%
ROA4.63%
Revenue Growth7.10%
Earnings Growth-36.50%
Balance Sheet
Debt/Equity1.00
Current Ratio1.53
Quick Ratio0.76
Book Value/Sh0.5803 GBp
Cash/Share0.0350 GBp
Dividends
Fwd Div Rate0.0500 GBp
Trail. Div Rate0.0720 GBp
Div. Yield2.58%
5Y Avg Yield2.08%
Payout Ratio78.71%
Ex-Div DateApr 16, 2026
Pay Date
Ownership
Shares Out.1.95B
Float1.95B
Insiders0.19%
Institutions80.68%
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)309.69 GBp
Target Range257.13 GBp372.26 GBp
# Analysts18
Company
Market Cap4.09B GBp
Enterprise Value5.52B GBp
Revenue (TTM)2.44B GBp
Gross Profit1.37B GBp
Net Income (TTM)175.00M GBp
Revenue/Share1.205 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees10.9K
Last Price206.60 GBp
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN